Silke Schelenz Selected Research

Silke Schelenz Research Topics

13	Infections 01/2022 - 08/2006
3	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 09/2018
3	Inflammation (Inflammations) 07/2015 - 04/2013
2	Critical Illness (Critically Ill) 01/2019 - 01/2008
2	Aspergillosis 04/2016 - 04/2015
2	Mycoses (Diseases, Fungus) 07/2015 - 08/2006
2	Neoplasms (Cancer) 01/2011 - 02/2010
1	Multiple Sclerosis 01/2022
1	Parasitic Diseases (Parasitic Disease) 01/2019
1	Invasive Candidiasis 01/2008
1	Infectious Arthritis (Septic Arthritis) 05/2007
1	Suppuration 08/2006
1	Urinary Tract Infections (Urinary Tract Infection) 08/2006
1	Pyonephrosis 08/2006
1	Arteriovenous Fistula 08/2003
1	Endocarditis 08/2003
1	Sepsis (Septicemia) 08/2003

6	Pharmaceutical PreparationsIBA 01/2022 - 08/2006
5	FicolinsIBA 01/2019 - 04/2013
4	AzolesIBA 01/2022 - 08/2006
3	Antifungal AgentsIBA 01/2011 - 08/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2011 - 05/2007
2	Interleukin-10 (Interleukin 10)IBA 04/2016 - 07/2015
2	Interleukin-8 (Interleukin 8)IBA 04/2016 - 07/2015
2	Interleukin-6 (Interleukin 6)IBA 04/2016 - 07/2015
2	Opsonin Proteins (Opsonins)IBA 10/2015 - 07/2015
1	Peptides (Polypeptides)IBA 01/2022
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2022
1	Glatiramer Acetate (Copaxone)FDA Link 01/2022
1	ceftazidime drug combination avibactamIBA 01/2021
1	ChlorhexidineIBA 01/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Pattern Recognition ReceptorsIBA 01/2016
1	InterleukinsIBA 07/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015
1	AntigensIBA 04/2015
1	Fibrinogen (Factor I)FDA Link 04/2013
1	CarbohydratesIBA 04/2013
1	AclarubicinIBA 02/2010
1	Topoisomerase InhibitorsIBA 02/2010
1	beta-Lactamases (beta-Lactamase)IBA 05/2007
1	Amikacin (A.M.K)FDA LinkGeneric 05/2007
1	Meropenem (Merrem)FDA LinkGeneric 05/2007
1	deoxycholate drug combination amphotericin BIBA 08/2006
1	Itraconazole (Sporanox)FDA LinkGeneric 08/2006
1	Fluconazole (Zonal)FDA LinkGeneric 08/2006
1	Caspofungin (Cancidas)FDA Link 08/2006
1	Polytetrafluoroethylene (Teflon)FDA Link 08/2003

2	Drug Therapy (Chemotherapy) 10/2019 - 01/2011
1	Duration of Therapy 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 01/2019
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2017
1	Protective Clothing 01/2016
1	Dentures 01/2011
1	Central Venous Catheters 01/2008
1	Catheters 08/2003
1	Renal Dialysis (Hemodialysis) 08/2003